Results 71 to 80 of about 6,465 (87)

A Modified Delphi Process to Develop Consensus Definitions of Time-Dependent Care by Paramedic Services Systems. [PDF]

Prehosp Disaster Med
de Montigny L, Lee R, Lang ES, Doig CJ, Blanchard IE.   +4 more
europepmc   +1 more source

Trends and Outcomes of Naloxone Use for Iatrogenic Opioid Overdose in Patients on General Wards in a Swiss Hospital: A Ten-Year Retrospective Case Series Analysis. [PDF]

Drug Healthc Patient Saf
Würsten M, Meyer-Massetti C, Leuppi-Taegtmeyer A, Goetschi AN.   +3 more
europepmc   +1 more source

Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto-Injector Versus Intranasal Naloxone. [PDF]

J Clin Pharmacol
Cipriano A, He E, Shet M, Apseloff G, Harris SC.   +4 more
europepmc   +1 more source

Targeting Na_v1.8 with the nonopioid antagonist suzetrigine for analgesia: cause for optimism? [PDF]

Br J Anaesth
Attal N, Barrot M.
europepmc   +1 more source

Involvement of central opioid and melanocortin receptors in spexin-induced hypophagia following intracerebroventricular injection in neonatal broiler chicks. [PDF]

BMC Vet Res
Badri M, Alimohammadi S, Zendehdel M, Hassanpour S.   +3 more
europepmc   +1 more source

Nalmefene Mitigates Opioid-Induced Nausea and Vomiting in Postoperative Analgesia but Not Resting Pain. [PDF]

Pain Res Manag
Yang J, Zhang B, Qiu L, Zeng Q, Xie J, Sun J.   +5 more
europepmc   +1 more source

Intranasal overdose reversal formulations: a rapid review of available agents. [PDF]

Pain Manag
Bernosky-Smith K, Painter O, Butler S, Patel D, Clemency B, Lynch J.   +5 more
europepmc   +1 more source

Structural Determinants of μ-Opioid Receptor Antagonism and Respiratory Liability in Phenylfentanyl Analogues. [PDF]

ACS Chem Neurosci
Li E, Kale BS, Silte AA, Lyu R, Upadhyay N, Neel LT, Reda A, Wang H, Dewey WL, Pagare PP, Zhang Y.   +10 more
europepmc   +1 more source

Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model-Based Evaluation of Important Pharmacological Attributes. [PDF]

Clin Pharmacol Ther
Chaturbedi A, Mann J, Chakravartula S, Thrasher B, Arabidarrehdor G, Zirkle J, Meshkin H, Nallani SC, Florian J, Li Z.   +9 more
europepmc   +1 more source

Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference. [PDF]

Neuropsychopharmacol Rep
Ide S, Iwase N, Arai K, Kojima M, Ushiyama S, Ikeda K.   +5 more
europepmc   +1 more source